Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Carol Anne Paronis, Ph.D.

Co-Author

This page shows the publications co-authored by Carol Paronis and Jack Bergman.
Connection Strength

4.312
  1. Long-Lasting In Vivo Effects of the Cannabinoid CB1 Antagonist AM6538. J Pharmacol Exp Ther. 2018 03; 364(3):485-493.
    View in: PubMed
    Score: 0.763
  2. Diuretic effects of cannabinoids. J Pharmacol Exp Ther. 2013 Jan; 344(1):8-14.
    View in: PubMed
    Score: 0.529
  3. Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal. J Pharmacol Exp Ther. 2011 Feb; 336(2):488-95.
    View in: PubMed
    Score: 0.464
  4. Measuring the reinforcing strength of abused drugs. Mol Interv. 2006 Oct; 6(5):273-83.
    View in: PubMed
    Score: 0.349
  5. Effects of cocaine under concurrent fixed ratio schedules of food and IV drug availability: a novel choice procedure in monkeys. Psychopharmacology (Berl). 2002 Oct; 163(3-4):283-91.
    View in: PubMed
    Score: 0.261
  6. Discriminative-Stimulus Effects of Synthetic Cathinones in Squirrel Monkeys. Int J Neuropsychopharmacol. 2021 08 20; 24(8):656-665.
    View in: PubMed
    Score: 0.245
  7. Different types of GABA(A) receptors may mediate the anticonflict and response rate-decreasing effects of zaleplon, zolpidem, and midazolam in squirrel monkeys. Psychopharmacology (Berl). 2001 Aug; 156(4):461-8.
    View in: PubMed
    Score: 0.244
  8. Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys. J Pharmacol Exp Ther. 1999 Sep; 290(3):1222-9.
    View in: PubMed
    Score: 0.214
  9. Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment. J Pharmacol Exp Ther. 2019 11; 371(2):544-554.
    View in: PubMed
    Score: 0.213
  10. Concurrent Assessment of the Antinociceptive and Behaviorally Disruptive Effects of Opioids in Squirrel Monkeys. J Pain. 2018 07; 19(7):728-740.
    View in: PubMed
    Score: 0.193
  11. Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux. J Pharmacol Exp Ther. 2010 Jun; 333(3):834-43.
    View in: PubMed
    Score: 0.111
  12. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats. Behav Pharmacol. 2007 Dec; 18(8):745-54.
    View in: PubMed
    Score: 0.095
  13. Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties. Physiol Behav. 2008 Mar 18; 93(4-5):666-70.
    View in: PubMed
    Score: 0.094
  14. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys. Eur J Pharmacol. 2007 Mar 08; 558(1-3):98-106.
    View in: PubMed
    Score: 0.088
  15. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. Neuropsychopharmacology. 2005 Apr; 30(4):758-64.
    View in: PubMed
    Score: 0.079
  16. Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys. J Pharmacol Exp Ther. 2004 Jan; 308(1):249-59.
    View in: PubMed
    Score: 0.071
  17. Evaluation of the novel antiepileptic drug, AWD 131-138, for benzodiazepine-like discriminative stimulus and reinforcing effects in squirrel monkeys. Eur J Pharmacol. 2003 Apr 04; 465(3):257-65.
    View in: PubMed
    Score: 0.069
  18. Reinforcing effects of synthetic cathinones in rhesus monkeys: Dose-response and behavioral economic analyses. Pharmacol Biochem Behav. 2021 03; 202:173112.
    View in: PubMed
    Score: 0.059
  19. The Intriguing Effects of Substituents in the N-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments. Molecules. 2020 Jun 06; 25(11).
    View in: PubMed
    Score: 0.056
  20. Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues. J Med Chem. 2016 07 28; 59(14):6903-19.
    View in: PubMed
    Score: 0.043
  21. Probing the carboxyester side chain in controlled deactivation (-)-d(8)-tetrahydrocannabinols. J Med Chem. 2015 Jan 22; 58(2):665-81.
    View in: PubMed
    Score: 0.039
  22. Controlled-deactivation cannabinergic ligands. J Med Chem. 2013 Dec 27; 56(24):10142-57.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.